Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia

Donor lymphocyte infusion (DLI) is commonly used to treat leukemia relapse following stem cell transplantation. In florid relapse, however, the efficacy of DLI is limited with substantial risk of severe graft-versus-host disease (GvHD). Here, we develop a novel risk-adapted strategy characterized by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rujkijyanont, P, Morris, C, Kang, G, Gan, K, Hartford, C, Triplett, B, Dallas, M, Srinivasan, A, Shook, D, Pillai, A, Pui, C-H, Leung, W
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3763390/
https://ncbi.nlm.nih.gov/pubmed/23995046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.39
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados